Nanoengineering of Porphyrin‐Based Biomaterials for Innovative Cancer Therapy
The Chemical Record · 2026-05 · 26 (5)
DOI: 10.1002/tcr.202500306 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift The Chemical Record, online erschienen am 10.03.2026. Verfasst von Yuzi Huang und 7 weiteren Autor:innen. Beteiligte Einrichtung: College of Materials and Chemical Engineering, China Three Gorges University, Yichang, Hubei, China. Hauptthemen laut MEDLINE: Porphyrins, Neoplasms, Biocompatible Materials, Antineoplastic Agents. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 263 Literaturangaben. Gefördert von: Natural Science Foundation of Hubei Province, National Natural Science Foundation of China, 111 Project.
Abstract (Originalsprache)
Cancer treatment faces significant challenges, including high invasiveness, systemic toxicity, and recurrence risks. Minimally invasive therapies such as photodynamic therapy (PDT), sonodynamic therapy (SDT), and photothermal therapy (PTT) have gained attention for their selectivity and low toxicity. Porphyrin‐based compounds, with excellent photo/sono‐sensitivity, are ideal for these therapies but face limitations like poor water solubility, aggregation, rapid metabolism, insufficient tumor targeting, and potential phototoxicity. Nanotechnology provides solutions: (1) Enhancing porphyrin's solubility and stability through strategies like liposomal encapsulation and polymer coating; (2) Using materials like hydrogen‐bond organic frameworks (HOFs) and metal‐organic frameworks (MOFs) to improve solubility, prevent aggregation, and enable efficient drug loading; (3) Developing tumor microenvironment‐responsive porphyrin‐based nanoplatforms for precise drug release, improving tumor targeting and reducing toxicity; (4) Integrating PDT/SDT/PTT with chemotherapy and immunotherapy for synergistic effects, overcoming resistance and metastasis. This review discusses the advances in multifunctional porphyrin‐based nanobiomaterials, highlighting their role in precision theranostics and synergistic therapy for next‐generation, low‐toxicity, high‐efficiency, personalized cancer treatments.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Materials and Chemical Engineering, China Three Gorges University, Yichang, Hubei, China.
- Hubei Three Gorges Laboratory, Yichang, Hubei, China.
- School of Nuclear Technology and Chemistry & Biology, Hubei Key Laboratory of Radiation Chemistry and Functional Materials, Hubei University of Science and Technology, Xianning, Hubei, China.
ORCID-Profile: Peng Geng
Förderung
- Natural Science Foundation of Hubei Province
- National Natural Science Foundation of China
- 111 Project
- Yichang Natural Science Research Program
Zitieren
APA
Huang, Y., Jin, Q., Wang, W., Zhang, Y., Geng, P., Yang, X., Luo, D., & Xiao, S. (2026). Nanoengineering of Porphyrin‐Based Biomaterials for Innovative Cancer Therapy. The Chemical Record, 26(5). https://doi.org/10.1002/tcr.202500306
Vancouver
Huang Y, Jin Q, Wang W, Zhang Y, Geng P, Yang X, et al. Nanoengineering of Porphyrin‐Based Biomaterials for Innovative Cancer Therapy. The Chemical Record. 2026;26(5). doi:10.1002/tcr.202500306
BibTeX
@article{Huang2026,
author = {Huang, Yuzi and Jin, Qiancheng and Wang, Wei and Zhang, Yuting and Geng, Peng and Yang, Xiaojie and Luo, Dan and Xiao, Shuzhang},
title = {Nanoengineering of Porphyrin‐Based Biomaterials for Innovative Cancer Therapy},
journal = {The Chemical Record},
year = {2026},
volume = {26},
number = {5},
doi = {10.1002/tcr.202500306}
}
EUVIMED